Dantrium Intravenous and Moxetumomab pasudotox
Determining the interaction of Dantrium Intravenous and Moxetumomab pasudotox and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: dantrolene
Brand name: Dantrium, Dantrium Intravenous, Revonto, Ryanodex
Synonyms: n.a.
Generic Name: moxetumomab pasudotox
Brand name: Lumoxiti
Synonyms: Moxetumomab Pasudotox
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Dantrium Intravenous-Moxetumomab Pasudotox-tdfk
- Dantrium Intravenous-Moxetumomab pasudotox-tdfk Intravenous
- Dantrium Intravenous-Moxifloxacin
- Dantrium Intravenous-Moxifloxacin (Systemic)
- Dantrium Intravenous-Moxifloxacin Hydrochloride
- Dantrium Intravenous-Moxifloxacin Injection
- Moxetumomab pasudotox-Dantrolene
- Moxetumomab pasudotox-Dantrolene Capsules
- Moxetumomab pasudotox-Dantrolene Injection
- Moxetumomab pasudotox-Dantrolene Intravenous
- Moxetumomab pasudotox-Dantrolene Sodium
- Moxetumomab pasudotox-Dapagliflozin